subject area of
- A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study Journal Articles
- Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. Journal Articles
- An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin Journal Articles
- Ca2+ and Zn2+ binding properties of peptide substrates of vertebrate collagenase, MMP-1 Journal Articles
- Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity Journal Articles
- Cardiac Sarcomeric Proteins: Novel Intracellular Targets of Matrix Metalloproteinase-2 in Heart Disease Journal Articles
- Doxycycline and other tetracyclines in the treatment of bone metastasis Journal Articles
- Editorial Comment on: Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor Journal Articles
- Effect of delivery of MMP inhibitors from PDMS as a model IOL material on PCO markers Journal Articles
- Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma Journal Articles
- Matrix Metalloproteinase Inhibitors Suppress Transforming Growth Factor-β-Induced Subcapsular Cataract Formation Journal Articles
- Matrix metalloproteinase-2 in oncostatin M-induced sarcomere degeneration in cardiomyocytes Journal Articles
- Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells. Journal Articles
- Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study Journal Articles
- Titin is a Target of Matrix Metalloproteinase-2 Journal Articles
- Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells. Journal Articles